CLINICAL SUPPLY MANAGEMENT ARTICLES
The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
FDA demographic mandates can upend global trial supply, stranding inventory, driving panic packaging, and creating hidden bias that undermines study execution.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
Explore the logistical risk management factors to consider when deciding to switch to direct-to-patient shipments in the EU.
-
Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.
-
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.
-
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.